Results 121 to 130 of about 3,125,349 (209)

Secrecy and Sustainability: How Concealment and Revelation Shape Vepsian Language Revival

, 2017
Laura Siragusa
semanticscholar   +1 more source

Decoding of image properties from single-trial visual evoked potentials recorded by ultra-high-density EEG. [PDF]

Sci Rep
Sieghartsleitner S, Schreiner L, Grünwald J, Jordan M, Spataro R, Scharinger J, Guger C.   +6 more
europepmc   +1 more source

PAUL ARISTE AND THE VEPS FOLKLORE

, 2005
Kirsti Salve
semanticscholar   +1 more source

AI cancer driver mutation predictions are valid in real-world data. [PDF]

Nat Commun
Tran TN, Fong C, Pichotta K, Luthra A, Shen R, Chen Y, Waters M, Kim S, Li X, de Bruijn I, Riely G, Berger MF, Ladanyi M, Chakravarty D, Schultz N, Jee J.   +15 more
europepmc   +1 more source

Computational exploration of global venoms for antimicrobial discovery with Venomics artificial intelligence. [PDF]

Nat Commun
Guan C, Torres MDT, Li S, de la Fuente-Nunez C.   +3 more
europepmc   +1 more source

Understanding the heterogeneous performance of variant effect predictors across human protein-coding genes. [PDF]

Sci Rep
Fawzy M, Marsh JA.
europepmc   +2 more sources

Creating an atlas of variant effects to resolve variants of uncertain significance and guide cardiovascular medicine. [PDF]

Nat Rev Cardiol
Glazer AM, Tabet DR, Parikh VN, Kroncke BM, Cote AG, Yamamoto Y, Wang Q, Muhammad A, Lancaster MC, O'Neill MJ, Weile J, Yang T, Macrae CA, Ashley EA, Roth FP, Roden DM.   +15 more
europepmc   +1 more source

The Incantations of the Veps People: Issues of Learning a Musical Language

Music Scholarship / Problemy Muzykal'noj Nauki, 2016
openaire   +1 more source

Guidelines for releasing a variant effect predictor. [PDF]

Genome Biol
Livesey BJ, Badonyi M, Dias M, Frazer J, Kumar S, Lindorff-Larsen K, McCandlish DM, Orenbuch R, Shearer CA, Muffley L, Foreman J, Glazer AM, Lehner B, Marks DS, Roth FP, Rubin AF, Starita LM, Marsh JA.   +17 more
europepmc   +1 more source

Disease-Modifying Treatment Options in Very Early Onset Multiple Sclerosis-What Choices Are There for Onset Under 5 Years of Age? A Systematic Review. [PDF]

J Clin Med
Craiu D, Dica AD, Pomeran C, Pescaru G, Menascu S, Simu M.   +5 more
europepmc   +1 more source